Reagenics Research Overview
Reagenics Research is a dual-platform biotech company developing solutions for the production of essential molecules. It uses a variety of genetics to produce high-quality and valuable molecules from plant, algae, and mushroom cell tissue. Reagenics has the means to scale up production of plant cell biomass in proprietary bioreactors, which will ensure the security, supply, and quality of these essential molecules.
Cumulative Funding Raised Over Time ($)
$3.0MOct 2021
Latest News
Not applicable
Margot Stern - The Future of Protein Production
The article discusses the importance of privacy and data storage when visiting websites. It explains that websites may store or retrieve data in your browser for basic functionality, marketing, analytics, and personalization purposes. The data stored can be used to deliver relevant advertising, remember user preferences, and understand how the website performs and how visitors interact with it. The article emphasizes the importance of privacy and gives users the option to disable certain types of storage that may not be necessary for the basic functioning of the website.
Not applicable
growth-positive
ReaGenics cracks code to produce 'commercially viable' quantities of cannabinoids, other bioactives via plant cell culture
Israeli startup ReaGenics has developed a novel method to produce commercially viable quantities of a broad spectrum of cannabinoids from cannabis plant cells. The company has also developed plant cell culture techniques to grow everything from saffron to coffee, peyote, resveratrol, and anthocyanins from purple maize. ReaGenics is in talks with an international conglomerate about partnering and another international company with an interest in plant proteins. The company recently partnered with a Colorado company that manufactures cannabinoid oils. ReaGenics has raised $3.3 million in seed funding and is now raising a $6 million low A round.
InvestmentPartners
growth-positive
Up the Ladder: ReaGenics Promotes Jonny Cline to Chief Operations Officer
ReaGenics, a plant molecular harvesting company, has promoted Jonny Cline to Chief Operations Officer (COO). Cline previously served as the companys operations and human resources executive vice president. He has extensive experience in senior roles in the start-up arena and in organizations in the social sector. ReaGenics recently announced a partnership with KND Labs, a leading manufacturer of nutraceutical ingredients, to enable KND to expand its product offerings in the global nutraceutical and ingredients marketplace.
Management ChangesPartners
growth-positive
Reagenics: Plant molecular harvesting in Israel
Reagenics plant cells in bioreactors. The cells can be used for food products, dyes, vitamins and food additives.
Reagenics, an Israeli company, is addressing the global food shortage by growing plant cells in bioreactors. These cells can be used for food products, dyes, vitamins, and food additives. Unlike traditional agriculture, bioreactors are not dependent on weather conditions, available land, or political unrest. The company has already scaled up by building bioreactors in Nes Ziona and a pilot plant in the Golan Heights, with plans to build a bioreactor in Denver, Colorado. Reagenics can grow plant cells four times faster than traditional agriculture and at a lower cost. The company is also working on other uses like cosmetics and food additives.
Expand
growth-positive
KND Labs and ReaGenics Announce Partnership to Expand Business Lines
KND Labs, a manufacturer of nutraceutical ingredients, has announced a partnership with Israel-based plant molecular harvesting company ReaGenics. The partnership will allow KND Labs to expand its product offerings in the global nutraceutical and ingredients marketplace. KND Labs currently serves many industries and is an ingredient partner to many of the world’s largest product brands. The ReaGenics partnership will enable KND Labs to apply its knowledge of scaled production to new ingredients. ReaGenics provides technology to support the growth of living plant stem cells economically and at scale.
PartnersExpand
| Sector | Agriculture & Food Technologies |
Funding
| Total funding | $3M |
| Last funding | $3M |
| Stage | Pre-Seed |
| Rounds | 1 |
| Investors | 0 |
Team Members
5
Employees: 1-10
Web & Social Links
| Website | www.reagenics.com |
Locations
Pinhas Sapir St 3, Ness Ziona, 7403626, Israel
Photos & Videos
1 item(s)
Reagenics Research Business
Business models
B2G, B2B
Product stage
R&D
Employees
1-10
Sector
Agriculture & Food TechnologiesAg TechGenetics & InputHealth Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringTarget Customer
Energy, Utilities & Waste ManagementNew FuelsBiofuelsAgriculture & FoodProcessed FoodsBeveragesIngredientsCropsRow CropsBroadacreVineHealthcare & Life SciencesLife SciencesCosmeticsPharmaceuticalsBiotechnologyHealthcareLaboratoriesCore Technology
Materials & SubstancesRaw MaterialsBiologicalsCellsTags (13)
stem-cellsplant-proteinfood-and-beveragecosmetic-companiesplant-protectionmedical-cannabisagtechbiotechnologymedical-technologiesagriculturebiomaterialsgastroenterologypharma-companiesGeographic Markets
East AsiaEuropeNorth AmericaReagenics Research Financials
$3M
Total funding
Undisclosed
Capital raised
$3M
Last funding
Pre-Seed
Funding stage
1
Total rounds
0
Investors
Cumulative Funding Raised Over Time ($)
$3.0MOct 2021
Private Equity Funding
Pre-Seed
Oct 2021
$3M
Reagenics Research Lifecycle
Cumulative Funding Raised Over Time
$3.0MOct 2021
All Events
Pre-Seed
Oct 2021
$3M
Reagenics Research News
9 articles
Not applicable
Margot Stern - The Future of Protein Production
The article discusses the importance of privacy and data storage when visiting websites. It explains that websites may store or retrieve data in your browser for basic functionality, marketing, analytics, and personalization purposes. The data stored can be used to deliver relevant advertising, remember user preferences, and understand how the website performs and how visitors interact with it. The article emphasizes the importance of privacy and gives users the option to disable certain types of storage that may not be necessary for the basic functioning of the website.
Not applicable
growth-positive
ReaGenics cracks code to produce 'commercially viable' quantities of cannabinoids, other bioactives via plant cell culture
Israeli startup ReaGenics has developed a novel method to produce commercially viable quantities of a broad spectrum of cannabinoids from cannabis plant cells. The company has also developed plant cell culture techniques to grow everything from saffron to coffee, peyote, resveratrol, and anthocyanins from purple maize. ReaGenics is in talks with an international conglomerate about partnering and another international company with an interest in plant proteins. The company recently partnered with a Colorado company that manufactures cannabinoid oils. ReaGenics has raised $3.3 million in seed funding and is now raising a $6 million low A round.
InvestmentPartners
growth-positive
Up the Ladder: ReaGenics Promotes Jonny Cline to Chief Operations Officer
ReaGenics, a plant molecular harvesting company, has promoted Jonny Cline to Chief Operations Officer (COO). Cline previously served as the companys operations and human resources executive vice president. He has extensive experience in senior roles in the start-up arena and in organizations in the social sector. ReaGenics recently announced a partnership with KND Labs, a leading manufacturer of nutraceutical ingredients, to enable KND to expand its product offerings in the global nutraceutical and ingredients marketplace.
Management ChangesPartners
growth-positive
Reagenics: Plant molecular harvesting in Israel
Reagenics plant cells in bioreactors. The cells can be used for food products, dyes, vitamins and food additives.
Reagenics, an Israeli company, is addressing the global food shortage by growing plant cells in bioreactors. These cells can be used for food products, dyes, vitamins, and food additives. Unlike traditional agriculture, bioreactors are not dependent on weather conditions, available land, or political unrest. The company has already scaled up by building bioreactors in Nes Ziona and a pilot plant in the Golan Heights, with plans to build a bioreactor in Denver, Colorado. Reagenics can grow plant cells four times faster than traditional agriculture and at a lower cost. The company is also working on other uses like cosmetics and food additives.
Expand
growth-positive
KND Labs and ReaGenics Announce Partnership to Expand Business Lines
KND Labs, a manufacturer of nutraceutical ingredients, has announced a partnership with Israel-based plant molecular harvesting company ReaGenics. The partnership will allow KND Labs to expand its product offerings in the global nutraceutical and ingredients marketplace. KND Labs currently serves many industries and is an ingredient partner to many of the world’s largest product brands. The ReaGenics partnership will enable KND Labs to apply its knowledge of scaled production to new ingredients. ReaGenics provides technology to support the growth of living plant stem cells economically and at scale.
PartnersExpand
growth-positive
Israeli startup growing plant cells for pharma, in the lab
ReaGenics, an Israeli startup, is leading the way in lab-grown plant cells for industrial scale, pharma-grade production. The company uses novel cell bioreactors to culture botanical molecules, a process that doesnt require large amounts of land and resources. The process starts with differentiated cells taken from a living plant, which are then decontaminated and placed in petri dishes. Instead of regenerating into a new plant, the cells are forced to revert to stem cells.
Expand
growth-positive
Growing plant cells for pharma in the lab: "Cannabis is challenging"
Israeli startup ReaGenics is leading the way in lab-grown plant technology, with a particular focus on cannabis and psilocybin. The company, which started in 2019, aims to treat inflammatory bowel disease with cannabis. However, achieving a consistent formulation of cannabinoids when the plants are grown outdoors or indoors is challenging. ReaGenics can generate the precise molecules needed to ensure cannabis consistency, which is crucial for the entourage effect.
CustomersExpand
growth-positive
Growing plant cells for pharma, in the lab - ISRAEL21c
Israeli startup ReaGenics is pioneering the cultivation of plant molecules in a lab, a process that could help mitigate the effects of climate change on crops and enable easier production of plants with medicinal properties. The company uses bioreactors to grow stem cells from plants, which can then be harvested for their molecules. The process could be used to produce a variety of products, from affordable saffron to consistent formulations of cannabinoids for medical use. ReaGenics has raised $3.3 million in funding and plans to build a production facility in Israel with up to 200 bioreactors.
InvestmentExpand
growth-positive
Israel Wants To Be The Capital Of Medical Cannabis
The iCanConnect Symposium, a pitch-day for Israeli and Israel-adjacent cannabis entrepreneurs, was held in midtown Manhattan. The event was run by CannaTech, a group that organizes international conferences for cannabis merchants. The symposium was attended by a number of startups seeking funding for cannabis-based businesses. Notably, the Israeli government is working on branding weed products and partnering internationally with regulators like the FDA to prepare for Israeli cannabis products to be exported. The event also highlighted the potential of cannabis for the Israeli economy and the need to overcome stigma and ignorance around cannabis.
InvestmentExpand
Reagenics Research Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 29 classification IDs that could be used for matching.
Reagenics Research Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Ortal Wein |
| Registrar ID | 515989192 |
| Crunchbase | reagenics-research |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Ortal Wein |
| Updater email | ortalw@sncentral.org |
| Last update | 2024-05-08T00:00:00.000Z |
| Created | 2019-03-03T00:00:00.000Z |
| Claimed | Yes |